Edward K. Aldag JR - Apr 15, 2025 Form 4 Insider Report for MEDICAL PROPERTIES TRUST INC (MPW)

Role: Chairman, President & CEO, Director
Signature: W. Zachary Riddle, by power of attorney
Stock symbol: MPW
Transactions as of: Apr 15, 2025
Transactions value $: -$78,524
Form type: 4
Date filed: 4/17/2025, 06:00 PM
Previous filing: Apr 3, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MPW	Common stock, par value $0.001	Tax liability	-$78.5K	-20.3K	-0.45%	$3.86	4.48M	Apr 15, 2025	Direct	F1, F2
transaction	MPW	Common stock, par value $0.001	Award	$0	+988K	+22.04%	$0.00	5.47M	Apr 15, 2025	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MPW	Restricted common stock units	Award	$0	+414K	+23%	$0.00	2.21M	Apr 15, 2025	Common stock, par value $0.001	414K	$0.00	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.
F2	The total amount of securities beneficially owned following the reported transaction includes a decrease of 234,566 shares as a result of forfeitures related to previously disclosed share awards.
F3	Shares vest at the beginning of each calendar quarter ending March 31, 2028.
F4	The restricted stock units were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period beginning April 15, 2025 (the "Grant Date") as follows: (i) if the Company's TSR reaches 20%, 100% of the restricted stock units will be earned; (ii) if the Company's TSR reaches 40%, 200% of the restricted stock units will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 5).
F5	Earned restricted stock units will be settled in cash (based on the average price of the Company's common stock over the five trading days ending on the applicable vesting date) in equal quarterly installments over one year following the date the restricted stock units are earned, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.